Four enzymatic methods for creatinine measurement were evaluated on a DuPont Dimension™ automatic analyzer. Biomed Creatinine-Duo-UV (BIO) and Raichem™ Creatinine Reagent Enzymatic (RAI) start creatinine breakdown with creatinine iminohydrolase (EC 3.5.4.21) resulting in the formation of NH/. The Boehringer Mannheim Creatinine PAP (BM1) and SopaChem Creatinine (SOP) start the breakdown of creatinine with creatininase (EC 3.5.2.10) which yields creatine. In order to reduce bilirubin interference, the BM1 method was modified to contain K 4 Fe(CN) 6 . This substance was added with reagent l (BM2) or with reagent 2 (BM3). All the enzymatic creatinine methods tested displayed good linearity for concentrations up to at least 1000 μπιοΐ/l. The ΒΙΟ, BM3, RAI and SOP methods showed good stability of test outcome for the tested period of a week. The outcome of the BM1 and BM2 method increased continually with time.
assay. These enzyme-based methods can follow two principally different reaction schemes. In the first reaction scheme creatinine is deaminated by creatinine deaminase (creatinine iminohydrolase, EC .3.5. 4 .21) yielding NHJ. This compound is measured in a subsequent reaction consuming NADPH or NADH which can be monitored photometrically. In the second reaction scheme creatinine is hydrolysed to creatine by creatininase (EC 3.5.2.10). The following breakdown of the formed creatine results eventually in the formation of H 2 O 2 , which is used for the formation of a quinone-imine dye by peroxidase.
In this study we evaluated four commercial enzymatic creatinine assays using a DuPont dimension™ automatic analyzer. Two methods are based on the creatinine iminohydrolase route: Biomed CreatinineDuo-UV (BIO) and Raichem™ Creatinine Reagent Enzymatic (RAI). The other two methods are based on the creatininase route: Boehringer Mannheim Creatinine PAP V (BM1) and SopaChem Creatinine (SOP).
A major problem in creatinine measurement is the interference caused by bilirubin. This is especially true for Jaffe methods (1) . However, the Boehringer Mannheim Creatinine PAP method also proved to be prone to bilirubin interference (8) . Adaptation of this method by addition of K 4 Fe(CN) 6 , which increases the specificity of the colour reaction (9) , resulted in better performance (10) . The original Boehringer Mannheim Creatinine PAP method is evaluated together with two modifications: K 4 Fe(CN) 6 was added with the first (BM2) or with the second reagent (BM3).
Interference caused by bilirubin was investigated in two ways. Firstly, solutions of creatinine in human albumin spiked with unconjugated or conjugated (ditauro-) bilirubin were assayed. Secondly, icteric patient specimens were analyzed and compared to the HPLC reference method (11). 
Materials and Methods

Materials
Statistical analysis
Regression analysis was done using the orthogonal Deming procedure. Intra-assay variation was calculated using series of 30 repetitive measurements of TestPoint unassayed chemistry control serum level 1 containing 93 μπιοΐ/ΐ creatinine. Interassay variation was determined using results of this same control serum measured in 12 assays performed on different days.
Results
Assay conditions provided with the reagents were transformed for use on the DuPont Dimension™ analyzer. As kinetic measurement yielded worse results in terms of precision than end-point measurement, the latter was the method of choice. For the methods employing the enzyme creatinine iminohydrolase (BIO and RAI) it was necessary to optimize the conditions. For an optimal results of the BIO method it was essential to restrict the mixing force to 'gentle', as stronger mixing led to an unacceptably high variation in the results. This probably resulted from the formation of foam interfering with correct measurement of absorbance in the case of non-delicate mixing. Assay conditions of the different methods are listed in table 2. The within-run and day-to-day imprecision found are given in table 3.
The enzymatic creatinine methods were tested for linearity using aqueous standards. For the BIO and RAI method the ratio between reagent 1 and sample was set to yield a linear result up to 1000 μπιοΐ/ΐ creatinine. BMx (BM1, BM2 and BM3) and SOP methods yielded linear results for creatinine concentrations up to 2000 μιηοΐ/ΐ. Linearity of the enzymatic methods was also investigated using a panel of 45 serum samples with varying creatinine concentrations up to 1000 μηαο1/1. These patient sera were not icteric, haemolytic or lipaemic. The results of these investigations are summarized in table 4 and closely agree with the results obtained with aqueous creatinine standards.
Stability of the reagents was verified using two control sera with creatinine concentrations of 93 and 650 μιηοΐ/ΐ and the standard provided with the SopaChem Creatinine reagent containing 177 μπιοΐ/ΐ creatinine. The methods were calibrated once and, subsequently, fresh samples were repeatedly analyzed, using the same reagents during a period of seven days. Figure  1 shows the results that were obtained using the TestPoint level 1 control serum with 93 μιηοΐ/ΐ cre- Solutions of 40 g/1 human albumin containing 100 or 300 μιηοΐ/ΐ creatinine were spiked with lipids (Intralipid™), haemoglobin, bilirubin or ditauro-bilirubin in order to investigate any interference caused by these substances. The solutions were measured using the different enzymatic methods for creatinine measurement. Figure 2 displays the results obtained using the albumin solutions with 100 μιηοΐ/ΐ creatinine. Closely agreeing results were obtained with the solutions with 300 μιηοΐ/ΐ (results not shown). The result of the RAI method was diminished by the presence of lipids, whereas the other methods were unaffected. Haemoglobin increased the outcome of the BIO method, whereas this slightly decreased the result of the RAI method. The BMx and SOP methods showed no interference with haemoglobin.
The BIO method was left almost unaffected by bilirubin concentrations up to 1000 μιηοΐ/ΐ for creatinine concentrations of 100 and 300 μιηοΐ/ΐ. Ditauro-bili- rubin caused an increase in test outcome that became quite dramatic when the ditauro-bilirubin concentration was higher than 700 μιηοΐ/ΐ. The outcome ofU;he BM1 method was strongly diminished by both bilirubin and ditauro-bilirubin. interference caused by these substances was reduced by addition of K 4 Fe(CN) 6 . Introduction of K 4 Fe(CN) 6 to the sample with the first reagent (BM2) yielded a slightly better reduction of interference than introduction with the second reagent (BM3). The RAI method displayed excellent resistance to interference by both bilirubin and ditauro-bilirubin at both the creatinine concentrations investigated. The outcome of the SOP method showed only a little less interference than the unmodified Boehringer Mannheim Creatinine PAP method (BM1). Creatinine was measured in a panel of 100 sera orig^· inating from patients with total bilirubin concentrations higher than 50 μιηοΐ/l. The obtained residuals, defined as test creatinine concentration minus concentration obtained by HPLC, are shown in relation to total bilirubin concentration in figure 3 . For the majority of the samples the ΒΙΟ, ΒΜ2, BM3 and RAI methods yielded results that were not influenced or only slightly so by the bilirubin concentration, although especially the BIO and RAI methods show some scatter for the remaining samples. However, when residuals were plotted in relation to creatinine concentration it was found that for the BIO method imprecision was high and the test outcome was elevated in the normal and low range (results not shown).
c The BM1 and SOP methods were strongly affected by bilirubin. These results are in close agreement with the interference studies using. J)ilirubin-spiked human albumin solutions. 
Discussion
In this study the evaluation of six automated methods for the enzymatic measurement of creatinine in serum is described. Four commercial kits were used for this purpose. A number of practical aspects regarding the performance of the various adaptations is given in the tables and the figures. Below we will try to find an explanation for some peculiarities.
For the BIO and RAI method the ratio between reagent 1 and sample was set to yield a linear result for creatinine concentrations up to 1000 μπιοΐ/ΐ. As the set dynamic range of these tests correlates inversely with the signal amplitude at physiological creatinine concentrations and, thus, to precision at this level, the ratio is a compromise between these quantities. However, the use of a larger sample volume relatively to the BMx or SOP methods did not reduce imprecision to a level close to that displayed by the latter methods (see tab. 3).
The outcome of the BIO method was raised by haemoglobin. It has been suggested that the creatinine concentration of haemoglobin-containing solutions is raised because of endogenous creatinine from erythrocytes that is liberated upon haemolysis (12) . The average creatinine concentration in erythrocytes is about 160 μπιοΐ/ΐ (13) . Because the maximal haemoglobin concentration investigated corresponds roughly to a 2% (vol/vol) erythrocyte homogenate, this phenomenon can maximally account for an increase in creatinine of about 3 μιηοΐ/ΐ. This was con-• firmed by HPLC measurement of creatinine in these haemolytic solutions. Therefore, the increase in the BIO method caused by haemoglobin represents interference.
Although both the BIO and RAI methods start creatinine breakdown with creatinine iminohydrolase (EC 3.5.4.21), they display quite different degrees of variation (see tab. 3). This might be related to the use of different coenzymes, since the RAI method employs NADPH whereas the BIO method uses NADH. Use of the coenzyme NADPH instead of NADH avoids the lengthy pre-incubation otherwise required for equilibrating interfering endogenous dehydrogenase reactions (14) . Therefore, the high variation in test outcome of the BIO method might be related to incomplete elimination of endogenous NH/ during the pre-incubation of 180 seconds. This was supported by our findings during the optimization procedure. However, selecting end-point instead of kinetic measurement resulted in a more pronounced reduction in variation (results not shown). As the maximal test duration of the DuPont Dimension™ is limited to 12 minutes, it was not possible to implement a configuration containing both a long pre-incubation and endpoint measurement.
Our findings for the BIO method implemented on the DuPont Dimension™ regarding the high variation of test outcome and the elevated results with samples containing low creatinine concentrations, are contrac dieted by other studies in which these problems were not encountered (15, 16 conclusion is that the BIO method is suited for routine creatinine measurement. This difference in outcome might result from the difference in average creatinine concentration of the samples investigated, which was lower in the present study as compared with the others (see tab. 1). The implementation of the enzymatic creatinine methods on the DuPont Dimension™ was a compromise between the recommendations of the various creatinine kit manufacturers and the capabilities of the Dimension™ analyzer. As suggested above it may be possible that lower variation can be obtained for the BIO method when using a test-configuration that runs beyond the maximal test duration of the Dimension™ analyzer.
Using the obtained results, test profiles can be compiled for the different methods (tab. 5) which contain linearity, stability, variation, interference by various substances and correlation with the HPLC reference method. As economics can nowadays not be excluded when selecting reagents, it is worth considering that the relative costs per enzymatic test are 10 to 20 times as high as for the conventional DuPont Jaffe creatinine Flex™ test. Taking alj analytical and clinical aspects into account, together with the high price of the enzymatic creatinine methods as compared with the Jaffe reaction-based tests, the question arises whether these enzymatic methods are satisfactory. It is up to the reader to decide. From this study we conclude that amongst the tested enzymatic methods the Boehringer Mannheim Creatinine PAP method, adapted to contain potassium hexacyanoferrate(II) (K 4 Fe(CN) 6 ) in reagent 2 (BM3), shows the best performance. Further studies are needed to determine whether the SopaChem Creatinine method, which is based on the same reaction principle, will show a comparable performance when adapted in a similar manner.
